After speaking with FDA manufacturing and quality control consultants, and senior execs from other generic injectable makers, Malhotra believes the Hospira violations meet FDA criteria for entering a consent decree.
FORBES: Hospira May Get A Consent Decree For Its Manufacturing Problems